FN Archimer Export Format PT J TI NMR Structure of rALF-Pm3, an Anti-Lipopolysaccharide Factor from Shrimp: Model of the Possible Lipid A-Binding Site BT AF YANG, Yinshan BOZE, Helene CHEMARDIN, Patrick PADILLA, Andre MOULIN, Guy TASSANAKAJON, Anchalee PUGNIERE, Martine ROQUET, Francoise DESTOUMIEUX GARZON, Delphine GUEGUEN, Yannick BACHERE, Evelyne AUMELAS, Andre AS 1:1;2:2;3:2;4:1;5:2;6:3;7:4;8:4;9:5;10:5;11:5;12:1; FF 1:;2:;3:;4:;5:;6:;7:;8:;9:;10:PDG-DOP-DCOP-AQUAPOL-LBQP;11:PDG-DOP-DCM-BOME;12:; C1 Univ Montpellier 1 & 2, INSERM, CNRS,U554, Ctr Biochim Struct,UMR5048, F-34090 Montpellier 9, France. Genie Microbiol & Enzymat, UMR SPO INRA, F-34060 Montpellier, France. Chulalongkorn Univ, Fac Sci, Dept Biochem, Shrimp Mol Biol & Genom Lab, Bangkok 10330, Thailand. Univ Montpellier 1, CPBS, F-34095 Montpellier, France. Univ Montpellier 2, CNRS, UMR Ecosyst Lagunaires 5119, IFREMER, F-34095 Montpellier 5, France. C2 CNRS, FRANCE INRA, FRANCE UNIV CHULALONGKORN, THAILAND UNIV MONTPELLIER, FRANCE IFREMER, FRANCE SI MONTPELLIER TAHITI PALAVAS SE PDG-DOP-DCM-BOME-LALR PDG-DOP-DCOP-AQUAPOL-LBQP PDG-DOP-DCM-BOME IN WOS Ifremer jusqu'en 2018 copubli-france copubli-p187 copubli-univ-france copubli-int-hors-europe copubli-sud IF 2.605 TC 63 UR https://archimer.ifremer.fr/doc/2009/publication-6320.pdf LA English DT Article DE ;Ultracentrifugation;Surface plasmon resonance;Septic shock;Structure;NMR;Lipid A;Lipopolysaccharide;Anti lipopolysaccharide factor AB The anti-lipopolysaccharide factor ALF-Pm3 is a 98-residue protein identified in hemocytes from the black tiger shrimp Penaeus monodon. It was expressed in Pichia pastoris from the constitutive glyceraldehyde-3-phosphate dehydrogenase promoter as a folded and N-15 uniformly labeled rALF-Pm3 protein. Its 3D structure was established by NMR and consists of three alpha-helices packed against a four-stranded beta-sheet. The C-34-C-55 disulfide bond was shown to be essential for the structure stability. By using surface plasmon resonance, we demonstrated that rALF-Pm3 binds to LPS, lipid A and to OM(R)-174, a soluble analogue of lipid A. Biophysical studies of rALF-Pm3/LPS and rALF-Pm3/OM(R)-174 complexes indicated rather high molecular sized aggregates, which prevented us to experimentally determine by NMR the binding mode of these lipids to rALF-Pm3. However, on the basis of striking structural similarities to the FhuA/LPS complex, we designed an original model of the possible lipid A-binding site of ALF-Pm3. Such a binding site, located on the ALF-Pm3 beta-sheet and involving seven charged residues, is well conserved in ALF-L from Limulus polyphemus and in ALF-T from Tachypleus tridentatus. In addition, our model is in agreement with experiments showing that beta-hairpin synthetic peptides corresponding to ALF-L beta-sheet bind to LPS. Delineating lipid A-binding site of ALFs will help go further in the de novo design of new antibacterial or LPS-neutralizing drugs. (C) 2008 Wiley Periodicals, Inc. Biopolymers 91: 207-220, 2009. PY 2009 PD MAR SO Biopolymers SN 0006-3525 PU Wiley / Blackwell VL 91 IS 3 UT 000262540400004 BP 207 EP 220 DI 10.1002/bip.21119 ID 6320 ER EF